Qualitative research · Messaging strategy and development · Commercialization · Product launch
CASE STUDY
MilliporeSigma had spent years advancing their portfolio in monoclonal antibody bioproduction, aiming to stay ahead in the industry. But they soon encountered a challenge—other competitors had achieved similar milestones, making it harder to stand out.
The Biopharma industry is highly concerned about and preoccupied with risk.
Instead of touting ‘end-to-end’ offerings, affirm the company’s commitment to partner with biopharma to mitigate unprecedented risks of globalization, biosimilars and virtual biotech companies.